Finance & markets · 28/10/20261 min read
CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets
Summary
SEOUL, South Korea, Oct. 28, 2026 — CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum…
Original source language: PR Newswire UK — News ReleasesOpen original release →